Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

27 Nov 2018 07:00

RNS Number : 5512I
Imaginatik PLC
27 November 2018
 

Imaginatik plc

("Imaginatik" or "the Company")

Result of Open Offer

 

On 2 November 2018 the Company announced details of an underwritten Open Offer to raise gross proceeds of up to approximately £252,578 through the issue of 22,961,687 new ordinary shares of £0.002 each ("Ordinary Shares") at 1.1 pence per share.

 

The Open Offer closed for acceptances at 11.00 a.m. on 26 November 2018 and the Company is pleased to announce that it has received valid acceptances under the Open Offer, including those received under the Excess Application Facility, in respect of 46,802,573 Ordinary Shares from Qualifying Shareholders. This represents demand for approximately 204 per cent. of the Open Offer Shares.

 

Qualifying Shareholders who have validly applied for Offer Shares will receive their Basic application in full and those Qualifying Shareholders who have validly applied for Excess Shares will receive approximately 33.10 per cent. of their Excess application on a pro rata basis, resulting in the issue of the full 22,961,687 Ordinary Shares under the Open Offer. Accordingly, the Company has not needed to call upon the underwriting facility.

 

Application has been made for the 22,961,687 new Ordinary Shares to be issued pursuant to the Open Offer to be admitted to trading on AIM. It is expected that admission of the new Ordinary Shares and commencement of dealings in the new Ordinary Shares will occur at 8.00 a.m. on 28 November 2018. Following Admission, the Enlarged Share Capital of the Company will consist of 71,949,673 Ordinary Shares. No Ordinary Shares are held in treasury.

 

The above figure of 71,949,673may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular to Shareholders dated 2 November 2018, copies of which are available on the Company's website at www.imaginatik.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

- ENDS -

 

For further information, please contact:

Imaginatik plc

Angus Forrest CEO

 

Via Alma PR (see contact details below)

WH Ireland - Nominated Adviser and joint broker

Mike Coe / Chris Savidge

 

Tel: +44 (0)117 945 3470

Peterhouse Capital Limited - Broker

Duncan Vasey / Lucy Williams

 

Tel: +44 (0) 20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

 

Tel: +44 (0) 20 8004 4218

 

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, TD Bank, Sodexo, Caterpillar and Cargill.

 

For more information visit www.imaginatik.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILFFLLLTLRFIT
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.